precisionFDA

The AutoML App-a-thon: Democratizing & Demystifying Artificial Intelligence Series #1 is now live! Submissions are being accepted now through April 26, 2024. For more information, and to get started, visit precision.fda.gov/challenges/32.

The AutoML App-a-thon: Democratizing & Demystifying Artificial Intelligence Series #1 launches on February 26, 2024! Help unlock new insights into its potential applications in healthcare and medicine! Pre-registration is open now through 2/22! precision.fda.gov/challenges/32

Thank you to everyone who participated in the Veterans Cardiac Health and AI Model Predictions (V-CHAMPS) Challenge!  Phase 2 results are in! Check out the challenge results page for insights on the Top Performers: precision.fda.gov/challenges/31/…

LIVE NOW: The media call on the approval of the first gene therapies to treat sickle cell disease is happening now! Stream it here ➡️ youtube.com/live/7m6kENCvx…

Today we approved two milestone treatments - the first cell-based gene therapies to treat sickle cell disease in patients 12 years and older. fda.gov/news-events/pr…

Thank you to everyone who participated in the V-CHAMPS Challenge! The results are in. Congratulations to our 13 Top Performers! View the Top Performers and challenge results here: precision.fda.gov/challenges/31/…

The V-CHAMPS Challenge submission deadline has been extended to August 2, 2023. For more information, and to submit your models, visit the Challenge site: precision.fda.gov/challenges/31

Help regulatory science by developing methods to augment training data & improve the robustness of baseline AI/ML-based software as a medical device (SaMD) in our latest challenge with @sagebio. Register here: synapse.org/#!Synapse:syn5…

The V-CHAMPs challenge is accepting submissions until July 26. Top Performers of Phase 1 will be invited to Phase 2, where models will be applied to real data. For more information & to submit your models, visit the challenge site precision.fda.gov/challenges/31

The Veterans Cardiac Health and AI Model Predictions (V-CHAMPS) Challenge is now live! Submissions are being accepted now through July 26. For more information and to get started, visit the challenge site: precision.fda.gov/challenges/31

Due to overwhelming demand, The Veterans Cardiac Health and AI Model Predictions (V-CHAMPS) Challenge will now be launching on Wednesday, May 24th! If interested, don't forget to pre-register at precision.fda.gov/challenges/31.

@VHAInnovation, @FDADeviceInfo, @precisionFDA, & @MHRAgovuk are launching the Veterans Cardiac Health & AI Model Predictions Challenge on May 22! Develop AI models to predict cardiac health outcomes using synthetic Veteran health records precision.fda.gov/challenges/31

Results from the Crowdsourced Evaluation of InChI-based Tautomer Challenge and next steps are now available: precision.fda.gov/challenges/29/…. Thank you to all participants!

Last call! The deadline for InChI-based Tautomer Identification Challenge is tomorrow, March 1. Submit your results here: precision.fda.gov/challenges/29

Check out our new blog! Experts discuss the redesign of handling of tautomerism for InChI V2. Read the full blog at: precision.fda.gov/experts/19/blog Reminder to submit results for InChI-based Tautomer Identification Challenge by 3/1: precision.fda.gov/challenges/29

Reminder! The InChI-based Tautomer Identification Challenge runs until March 1. The challenge tests a modified InChI algorithm, designed for advanced recognition of tautomers, against real chemical samples. To participate, visit the challenge site: precision.fda.gov/challenges/29

Computational modeling and simulation (M&S) are powerful tools that complement traditional methods for gathering evidence about products regulated by FDA.

Calling all academic & industry chemists! The InChI Trust, the IUPAC Working Group on Tautomers, & FDA just launched the InChI-based Tautomer Identification Challenge! For more information & to participate, visit the challenge site here: precision.fda.gov/challenges/29 #InChI2022

Updated COVID vaccines offer you the only targeted protection you can get against the Omicron strain out there now. #VaxUpAmerica

Calling all academic & industry chemists! This month, the InChI Trust, the IUPAC Working Group on Tautomers, & FDA are launching the InChI-based based Tautomer Identification Challenge. Learn more & pre-register: precision.fda.gov/challenges/24 #InChI2022 #Chemistry #Cheminformatics